In an integrated audit of internal control over financial reporting and the financial statements, the auditor also may use this work to obtain evidence supporting the auditor's assessment of control risk for purposes of the audit of the financial statements.
A new development in uveitis treatment during the past few years is the increased use of tumor necrosis alpha (TNF-Î±) inhibitors, specifically infliximab (Remicade, Janssen Biotech Inc.) and adalimumab (Humira, Abbott Laboratories).
Options may include: 1  Phototherapy with ultraviolet (UV) light (either UVB light or UVA combined with drugs called psoralens, known as PUVA) 2  Topical chemotherapy with BCNU or nitrogen mustard. 3  Topical corticosteroid ointments or injections. 4  Topical retinoids (vitamin A-like drugs), such as bexarotene. 5  Topical imiquimod.